市場調査レポート

商品コード

感染症診断市場規模・予測、製品・技術・用途タイプ・検査タイプ・エンドユーザー・地域別の世界・地域シェア、動向、成長機会分析

Infectious Disease Diagnostics Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Product, Technology , Application Type, Testing Type, End User, and Geography

出版日: 2023年11月07日 | 発行: The Insight Partners

| ページ情報: 英文 280 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 4,550 712,985円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,550 1,026,385円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,550 1,339,785円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.70円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

感染症診断市場は、2022年の383億6,600万米ドルから2030年には599億5,400万米ドルに成長すると予測されており、2022年から2030年までのCAGRは5.7%と予測されています。世界の感染症罹患率の上昇と、獣医感染症における診断薬の用途拡大が、感染症診断市場規模を押し上げています。しかし、不十分な償還シナリオが感染症診断市場の成長を阻害しています。

感染症罹患率の上昇が感染症診断市場の成長を牽引

真菌、ウイルス、寄生虫、細菌、有毒生成物などは、感染症を引き起こす可能性のある感染因子の1つです。公衆衛生は感染症によって悪影響を受け、罹患率、死亡率、経済的負担を引き起こします。感染症の増加により、効果的な疾病管理、治療、予防の基礎となる正確でタイムリーな診断の必要性が高まっています。C型肝炎、HIV、結核、ヒトパピローマウイルス、性感染症（STI）など複数の感染症や疾患、感染症アウトブレイクの診断とモニタリングは、分子診断技術、検査室ベースのアッセイ、ポイントオブケア検査を用いて行うことができます。米国疾病予防管理センター（CDC）によると、アフリカ諸国では毎年1,020万人が感染症や寄生虫症の治療のために医院を訪れています。2021年にNational Library of Medicine（NLM）に掲載された論文によると、感染症は疾病負担が大きくヘルスケア資源が限られているため、ほとんどのアフリカ諸国で大きな懸念となっています。ナイジェリアでは200以上の病原体が発熱を引き起こす可能性があり、ヘルスケア施設を訪れる最も一般的な理由の一つとなっています。世界保健機関（WHO）によると、世界中で5,800万人以上がC型慢性肝炎に罹患しており、毎年150万人が新たに感染していると診断されています。HIVは世界中で公衆衛生上の大きな問題となっています。国連合同エイズ計画（UNAIDS）によると、2020年には3,770万人がHIVに感染しています。そのうち3,600万人が成人で、0～14歳の子どもが約170万人です。また、2020年に世界で新たに報告されたHIV感染者は～150万人です。

WHOによると、結核は世界全体の死因の第13位であり、COVID-19に次いで死亡につながる感染症の第2位です。WHOによると、2020年には結核が原因で150万人が死亡すると言われています。WHOは全世界で1,000万人が結核に罹患していると考え、さらに2020年には、結核の罹患率が高い30カ国が結核新規患者の86％を占めると予測しています。インドを筆頭に、中国、フィリピン、インドネシア、ナイジェリア、パキスタン、バングラデシュ、南アフリカの8カ国が結核患者全体の3分の2を占めています。このように、感染症の急増は、微生物培養、赤血球凝集阻害試験、酵素結合免疫吸着測定法（ELISA）などの感染症診断技術の必要性を高めています。

本レポートでは、感染症診断市場を以下のように区分しています：

感染症診断市場を製品別に分類すると、キット＆試薬、機器、ソフトウェア＆サービスに分けられます。感染症診断市場を技術別に分類すると、バイオセンサー、免疫診断、分子診断、臨床生物学、その他に分けられます。免疫診断市場は、さらに酵素結合免疫吸着分析、ウェスタンブロット分析、免疫蛍光分析に区分されます。分子ベースの診断技術市場は、さらにポリメラーゼ連鎖反応、in situハイブリダイゼーション、等温核酸増幅技術、次世代シーケンシング、DNAマイクロアレイ、その他に区分されます。感染症診断市場は、用途別に、ポイントオブケア検査とラボ検査に二分されます。感染症診断市場は、検査タイプ別にヒト用検査と動物用検査に二分されます。ヒト検査市場はさらに、HIV、肝炎、HAI、HPV、結核、インフルエンザ、その他に区分されます。エンドユーザー別の感染症診断市場は、診断ラボ、病院・診療所、研究機関、在宅医療現場、その他に区分されます。地域別では、感染症診断市場は北米（米国、カナダ、メキシコ）、欧州（英国、ドイツ、フランス、イタリア、スペイン、その他欧州地域）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、その他アジア太平洋地域）、中東・アフリカ（アラブ首長国連邦、サウジアラビア、韓国、オーストラリア、その他中東・アフリカ地域）、南米（ブラジル、アルゼンチン、その他中東・アフリカ地域）に区分されます。

製品別洞察

感染症診断市場は、製品別にキット＆試薬、機器、ソフトウェア＆サービスに区分されます。2022年には、キット＆試薬セグメントが市場で最大のシェアを占めました。しかし、ソフトウェア＆サービス分野の市場は2022～2030年に最も速い速度で成長すると予想されます。

地域別洞察

地域別に見ると、感染症診断市場は北米、欧州、アジア太平洋、中東・アフリカ、中南米に区分されます。北米は世界の感染症診断市場の成長に最も貢献しています。アジア太平洋地域は、2022-2030年の感染症診断市場において最も高いCAGRを記録すると予測されています。米国における感染症診断市場の成長は、主に感染症の流行増加、高齢者人口の増加、主要企業による製品上市数の増加によってもたらされます。

Abbott Laboratories、Bruker Corp、Cardinal Health、F. Hoffmann-La Roche Ltd、Trinity Biotech Plc、Danaher Corp、Bio-Rad Laboratories Inc、AccuBioTech Co Ltd、ACON Laboratories、DiaSorin SpAなどが、感染症診断市場で事業を展開する有力企業です。これらの企業は、世界中で拡大する消費者の需要に対応し、専門的なポートフォリオの製品範囲を拡大するため、新製品の発売や地理的拡大に注力しています。世界なプレゼンスにより、多くの顧客にサービスを提供し、市場の拡大を促進しています。

感染症診断市場に関する本レポートの作成にあたり参照した主な一次情報および二次情報には、世界保健機関（WHO）、米国国勢調査局、The Journal for Infectious Diseases、International Journal of Infectious Diseases、CDCなどがあります。

市場促進要因：
- 感染症罹患率の上昇
- 獣医感染症における診断薬の用途拡大
市場抑制要因
- 不十分な償還シナリオ
市場機会
- 感染症診断の研究開発と資金調達への注目の高まり
今後の動向
- 製品の承認・上市数の増加
影響分析

第6章感染症診断市場- 世界市場分析

感染症診断市場の収益、2022年～2030年

第7章感染症診断の世界市場-2030年までの収益と予測-製品別

概要
感染症診断市場の収益シェア、製品別（2022年・2030年）
キット・試薬
機器
ソフトウェア＆サービス

第8章感染症診断の世界市場-2030年までの収益と予測-技術別

概要
感染症診断市場の収益シェア、技術別、2022年および2030年
バイオセンサーベース
免疫診断薬
分子ベースの診断技術
臨床生物学
その他

第9章感染症診断の世界市場-2030年までの収益と予測-用途別

概要
感染症診断市場の収益シェア、2022年および2030年、用途別
ポイントオブケア検査
ラボ検査

第10章感染症診断の世界市場：2030年までの収益と予測：検査タイプ別

概要
感染症診断市場の収益シェア、2022年および2030年、検査タイプ別
ヒト検査
動物用検査

第11章感染症診断の世界市場-2030年までの収益と予測-エンドユーザー別

概要
感染症診断市場の収益シェア、（2022年・2030年）、エンドユーザー別
診断研究所
病院・診療所
研究機関
在宅介護の現場
その他

第12章感染症診断市場：地域別分析

概要
北米：感染症診断市場：製品別、2020年～2030年
北米：感染症診断市場：技術別、2020年～2030年
- 北米：感染症診断市場：技術別、免疫診断薬、2020-2030年
- 北米：感染症診断市場：分子ベース診断技術：技術別、2020-2030年
北米：感染症診断市場：用途別、2020-2030年
北米：感染症診断市場：検査タイプ別、2020-2030年
- 北米：人体検査用感染症診断市場：検査タイプ別、2020-2030年
北米：感染症診断市場：エンドユーザー別、2020-2030年
北米の感染症診断市場：国別
- 米国
- カナダ
- メキシコ
概要
欧州：感染症診断市場：製品別、2020-2030年
欧州：感染症診断市場：技術別、2020-2030年
- 欧州：感染症診断の市場：技術別、2020-2030年
- 欧州：感染症診断市場：分子ベース診断技術：技術別、2020-2030年
欧州：感染症診断市場：用途別、2020-2030年
欧州：感染症診断市場：検査タイプ別、2020-2030年
- 欧州：感染症診断市場：ヒト検査用、検査タイプ別、2020-2030年
欧州：感染症診断市場：エンドユーザー別、2020-2030年
欧州の感染症診断市場：国別
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- その他欧州
概要
アジア太平洋地域：感染症診断市場：製品別、2020年～2030年
アジア太平洋地域：感染症診断市場：技術別、2020-2030年
- アジア太平洋地域：感染症診断市場：技術別、免疫診断薬、2020-2030年
- アジア太平洋地域：感染症診断市場：分子ベース診断技術：技術別、2020-2030年
アジア太平洋地域：感染症診断市場：用途別、2020-2030年
アジア太平洋地域：感染症診断市場：検査タイプ別、2020-2030年
- アジア太平洋地域：人体検査用感染症診断市場：検査タイプ別、2020-2030年
アジア太平洋地域：感染症診断市場：エンドユーザー別、2020年～2030年
アジア太平洋地域の感染症診断市場：国別
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- その他アジア太平洋地域
概要
中東・アフリカ：感染症診断市場：製品別、2020年～2030年
中東・アフリカ：感染症診断市場：技術別、2020-2030年
- 中東・アフリカ：感染症診断市場：技術別、免疫診断薬、2020-2030年
- 中東・アフリカ：感染症診断市場：分子ベース診断技術：技術別、2020-2030年
中東・アフリカ：感染症診断市場：用途別、2020-2030年
中東・アフリカ：感染症診断市場：検査タイプ別、2020-2030年
- 中東・アフリカ：人体検査用感染症診断市場：検査タイプ別、2020-2030年
中東・アフリカ：感染症診断市場：エンドユーザー別、2020-2030年
- 中東・アフリカ：感染症診断市場：国別
- サウジアラビア
- 南アフリカ
- アラブ首長国連邦
- その他中東とアフリカ
概要
中南米：感染症診断市場：製品別、2020年～2030年
中南米：感染症診断市場：技術別、2020年～2030年
- 中南米：感染症診断市場：免疫診断、技術別、2020-2030年
- 中南米：感染症診断市場：分子ベース診断技術：技術別、2020～2030年
中南米：感染症診断市場：用途別、2020-2030年
中南米：感染症診断市場：検査タイプ別、2020-2030年
- 中南米：人体検査用感染症診断市場：検査タイプ別、2020-2030年
中南米：感染症診断市場：エンドユーザー別、2020-2030年
中南米：感染症診断市場：国別
- ブラジル

図表

List Of Tables

Table 1. Infectious Disease Diagnostics Market Segmentation. 40
Table 2. Infectious Diseases and Fundings. 51
Table 3. Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 63
Table 4. Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 64
Table 5. Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 73
Table 6. North America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 83
Table 7. North America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 84
Table 8. North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 84
Table 9. North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 85
Table 10. North America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 85
Table 11. North America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 86
Table 12. North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 86
Table 13. North America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 87
Table 14. US Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 88
Table 15. US Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 90
Table 16. US Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 90
Table 17. US Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 91
Table 18. US Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 92
Table 19. US Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 92
Table 20. US Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 92
Table 21. US Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 93
Table 22. Canada Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 95
Table 23. Canada Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 96
Table 24. Canada Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 96
Table 25. Canada Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 97
Table 26. Canada Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 97
Table 27. Canada Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 98
Table 28. Canada Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 98
Table 29. Canada Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 99
Table 30. Mexico Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 101
Table 31. Mexico Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 102
Table 32. Mexico Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 102
Table 33. Mexico Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 103
Table 34. Mexico Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 103
Table 35. Mexico Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 103
Table 36. Mexico Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 104
Table 37. Mexico Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 104
Table 38. Europe Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 106
Table 39. Europe Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 107
Table 40. Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 107
Table 41. Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 108
Table 42. Europe Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 108
Table 43. Europe Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 109
Table 44. Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 109
Table 45. Europe Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 110
Table 46. UK Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 111
Table 47. UK Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 113
Table 48. UK Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 113
Table 49. UK Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 114
Table 50. UK Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 114
Table 51. UK Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 115
Table 52. UK Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 115
Table 53. UK Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 116
Table 54. Germany Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 118
Table 55. Germany Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 119
Table 56. Germany Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 119
Table 57. Germany Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 120
Table 58. Germany Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 120
Table 59. Germany Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 121
Table 60. Germany Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 121
Table 61. Germany Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 122
Table 62. France Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 123
Table 63. France Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 125
Table 64. France Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 125
Table 65. France Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 126
Table 66. France Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 126
Table 67. France Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 127
Table 68. France Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 127
Table 69. France Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 128
Table 70. Italy Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 129
Table 71. Italy Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 131
Table 72. Italy Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 131
Table 73. Italy Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 132
Table 74. Italy Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 132
Table 75. Italy Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 132
Table 76. Italy Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 133
Table 77. Italy Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 133
Table 78. Spain Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 134
Table 79. Spain Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 136
Table 80. Spain Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 136
Table 81. Spain Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 137
Table 82. Spain Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 137
Table 83. Spain Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 137
Table 84. Spain Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 138
Table 85. Spain Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 138
Table 86. Rest of Europe Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 140
Table 87. Rest of Europe Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 141
Table 88. Rest of Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 141
Table 89. Rest of Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 142
Table 90. Rest of Europe Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 142
Table 91. Rest of Europe Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 143
Table 92. Rest of Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 143
Table 93. Rest of Europe Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 144
Table 94. Asia Pacific Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 146
Table 95. Asia Pacific Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 147
Table 96. Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 147
Table 97. Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 148
Table 98. Asia Pacific Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 148
Table 99. Asia Pacific Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 149
Table 100. Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 149
Table 101. Asia Pacific Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 150
Table 102. China Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 153
Table 103. China Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 153
Table 104. China Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 154
Table 105. China Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 154
Table 106. China Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 155
Table 107. China Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 155
Table 108. China Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 156
Table 109. China Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 156
Table 110. Japan Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 157
Table 111. Japan Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 159
Table 112. Japan Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 159
Table 113. Japan Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 160
Table 114. Japan Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 160
Table 115. Japan Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 160
Table 116. Japan Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 161
Table 117. Japan Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 161
Table 118. India Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 162
Table 119. India Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 164
Table 120. India Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 164
Table 121. India Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 165
Table 122. India Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 165
Table 123. India Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 165
Table 124. India Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 166
Table 125. India Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 166
Table 126. South Korea Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 167
Table 127. South Korea Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 169
Table 128. South Korea Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 169
Table 129. South Korea Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 170
Table 130. South Korea Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 170
Table 131. South Korea Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 170
Table 132. South Korea Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 171
Table 133. South Korea Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 171
Table 134. Australia Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 172
Table 135. Australia Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 174
Table 136. Australia Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 174
Table 137. Australia Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 175
Table 138. Australia Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 175
Table 139. Australia Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 175
Table 140. Australia Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 176
Table 141. Australia Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 176
Table 142. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 177
Table 143. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 179
Table 144. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 179
Table 145. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 180
Table 146. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 180
Table 147. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 181
Table 148. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 181
Table 149. Rest of Asia Pacific Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 182
Table 150. Middle East & Africa Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 184
Table 151. Middle East & Africa Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 185
Table 152. Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 185
Table 153. Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 186
Table 154. Middle East & Africa Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 186
Table 155. Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 187
Table 156. Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 187
Table 157. Middle East & Africa Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 188
Table 158. Saudi Arabia Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 189
Table 159. Saudi Arabia Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 191
Table 160. Saudi Arabia Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 191
Table 161. Saudi Arabia Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 192
Table 162. Saudi Arabia Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 192
Table 163. Saudi Arabia Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 192
Table 164. Saudi Arabia Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 193
Table 165. Saudi Arabia Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 193
Table 166. Saudi Arabia Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 194
Table 167. South Africa Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 196
Table 168. South Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 196
Table 169. South Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 197
Table 170. South Africa Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 197
Table 171. South Africa Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 197
Table 172. South Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 198
Table 173. South Africa Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 198
Table 174. UAE Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 199
Table 175. UAE Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 201
Table 176. UAE Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 201
Table 177. UAE Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 202
Table 178. UAE Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 202
Table 179. UAE Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 202
Table 180. UAE Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 203
Table 181. UAE Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 203
Table 182. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 204
Table 183. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 206
Table 184. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 206
Table 185. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 207
Table 186. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 207
Table 187. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 208
Table 188. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 208
Table 189. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 209
Table 190. South & Central America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 211
Table 191. South & Central America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 212
Table 192. South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 212
Table 193. South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 213
Table 194. South & Central America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 213
Table 195. South & Central America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 214
Table 196. South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 214
Table 197. South & Central America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 215
Table 198. Brazil Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 216
Table 199. Brazil Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 218
Table 200. Brazil Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 218
Table 201. Brazil Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 219
Table 202. Brazil Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 219
Table 203. Brazil Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 219
Table 204. Brazil Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 220
Table 205. Brazil Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 220
Table 206. Argentina Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 221
Table 207. Argentina Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 223
Table 208. Argentina Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 223
Table 209. Argentina Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 224
Table 210. Argentina Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 224
Table 211. Argentina Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 224
Table 212. Argentina Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 225
Table 213. Argentina Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 225
Table 214. Rest of South & Central America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million) 226
Table 215. Rest of South & Central America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million) 227
Table 216. Rest of South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million) 227
Table 217. Rest of South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million) 228
Table 218. Rest of South & Central America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million) 228
Table 219. Rest of South & Central America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million) 229
Table 220. Rest of South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million) 229
Table 221. Rest of South & Central America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million) 230
Table 222. Organic Developments Done By Companies. 232
Table 223. Inorganic Developments Done By Companies. 234
Table 224. Glossary of Terms, Infectious Disease Diagnostics Market 278

List Of Figures

Figure 1. Infectious Disease Diagnostics Market Segmentation, By Geography. 41
Figure 2. Global - PEST Analysis. 47
Figure 3. Infectious Disease Diagnostics Market - Key Industry Dynamics. 48
Figure 4. Impact Analysis of Drivers and Restraints. 53
Figure 5. Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030. 54
Figure 6. Infectious Disease Diagnostics Market Revenue, Geography (US$ Mn), 2022 - 2030. 55
Figure 7. Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%) 56
Figure 8. Kits & Reagents: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 57
Figure 9. Instruments: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 58
Figure 10. Software & Services: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 59
Figure 11. Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%) 60
Figure 12. Biosensor-based: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 61
Figure 13. Immunodiagnostics: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 62
Figure 14. Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 64
Figure 15. Clinical Biology: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 66
Figure 16. Others: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 67
Figure 17. Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%) 68
Figure 18. Point-of-Care Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 69
Figure 19. Laboratory Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 70
Figure 20. Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%) 71
Figure 21. Human Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 72
Figure 22. Veterinary Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 74
Figure 23. Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%) 75
Figure 24. Diagnostic Laboratories: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 76
Figure 25. Hospitals and Clinics: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 77
Figure 26. Research Institutes: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 78
Figure 27. Homecare Settings: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 80
Figure 28. Others: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 81
Figure 29. North America: Infectious Disease Diagnostics Market, by Key Country - Revenue (2022) (US$ Million) 82
Figure 30. North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 83
Figure 31. North America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 87
Figure 32. US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 88
Figure 33. Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 94
Figure 34. Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 100
Figure 35. Europe Infectious Disease Diagnostics Market, by Key Country - Revenue, 2022 (US$ Million) 105
Figure 36. Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 106
Figure 37. Europe Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 110
Figure 38. UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 111
Figure 39. Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 117
Figure 40. France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 123
Figure 41. Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 129
Figure 42. Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 134
Figure 43. Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 139
Figure 44. Asia Pacific Infectious Disease Diagnostics Market, by Key Country - Revenue, 2022 (US$ Million) 145
Figure 45. Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 146
Figure 46. Asia Pacific Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 151
Figure 47. China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 151
Figure 48. Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 157
Figure 49. India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 162
Figure 50. South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 167
Figure 51. Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 172
Figure 52. Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 177
Figure 53. Middle East & Africa Infectious Disease Diagnostics Market, by Key Country - Revenue, 2022 (US$ Million) 183
Figure 54. Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 184
Figure 55. Middle East & Africa Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 188
Figure 56. Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 189
Figure 57. South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 194
Figure 58. UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 199
Figure 59. Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 204
Figure 60. South & Central America Infectious Disease Diagnostics Market, by Key Country - Revenue, 2022 (US$ Million) 210
Figure 61. South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 211
Figure 62. South & Central America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 215
Figure 63. Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 216
Figure 64. Argentina Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 221
Figure 65. Rest of South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 226
Figure 66. Growth Strategies Done by the Companies in the Market, (%) 231

Product Code: TIPHE100001430

The infectious disease diagnostics market is expected to grow from US$ 38.366 billion in 2022 to US$ 59.954 billion by 2030; it is anticipated to register a CAGR of 5.7% from 2022 to 2030. The growing incidence of infectious diseases across the world and rising application of diagnostics in veterinary infectious diseases bolster the infectious disease diagnostics market size. However, an inadequate reimbursement scenario hinders the infectious disease diagnostics market growth.

Rising Incidence of Infectious Diseases Drive Infectious Disease Diagnostics Market Growth

Fungi, viruses, parasites, bacteria, and toxic products are among the infectious agents that can cause infectious diseases. Public health is adversely affected by infectious diseases, causing morbidity, mortality, and economic burdens. Rising incidence of infectious diseases propels the requirement for accurate and timely diagnosis to form the basis for effective disease management, treatment, and prevention. Diagnosing and monitoring multiple infections and diseases, including hepatitis C, HIV, tuberculosis, human papillomavirus, and sexually transmitted infections (STIs), and infectious disease outbreaks can be performed using molecular diagnostics techniques, laboratory-based assays, and point-of-care tests. According to the Centers for Disease Control and Prevention (CDC), ~10.2 million people visited physician offices for the treatment of infectious and parasitic diseases in African countries every year. According to an article published in the National Library of Medicine (NLM) in 2021, infectious diseases are a major concern in most African countries due to high disease burden and limited healthcare resources. More than 200 pathogens can cause fever in Nigeria, one of the most common reasons for visiting a healthcare facility. According to the World Health Organization (WHO), ~58 million people across the world suffer from chronic hepatitis C infection, and ~1.5 million new infections are diagnosed every year. HIV is a major public health issue across the world. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2020, ~ 37.7 million people had HIV. Out of these, ~36 million people were adults, and about 1.7 million were children aged 0-14 years. Also, ~1.5 million new HIV cases were reported globally in 2020.

According to WHO, tuberculosis (TB) is the 13th leading cause of death across the world, and it is the second leading infectious disease that leads to death after COVID-19. According to the WHO, 1.5 million deaths were caused by TB in 2020. In 2020, WHO projected that 10 million people had TB across the world, Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Eight countries make up two-thirds of the total cases of TB, with India at the forefront, followed by China, the Philippines, Indonesia, Nigeria, Pakistan, Bangladesh, and South Africa. Thus, the upsurging incidence of infectious diseases bolsters the need for infectious disease diagnostic technologies, such as microbial culture, hemagglutination inhibition tests, and enzyme-linked immunosorbent assays (ELISA).

The report segments the infectious disease diagnostics market as follows:

The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. The infectious disease diagnostics market, by technology, is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic, clinical biology, and others. The market for the immunodiagnostics segment is further segmented into enzyme-linked immunosorbent assay, western blotting analysis, and immunofluorescence assay. The market for the molecular-based diagnostic techniques segment is further segmented into polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, next generation sequencing, DNA microarrays, and others. The infectious disease diagnostics market, by application type, is bifurcated into point-of-care testing and laboratory testing. The infectious disease diagnostics market, by testing type, is bifurcated into human testing and veterinary testing. The market for the human testing segment is further segmented into HIV, Hepatitis, HAIs, HPV, tuberculosis, influenza, and others. The infectious disease diagnostics market, by end user, is segmented into diagnostic laboratories, hospitals and clinics, research institutes, homecare settings, and others. Based on geography, the infectious disease diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Product-Based Insights

The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. In 2022, the kits & reagents segment held the largest share of the market. However, the market for the software & services segment is expected to grow at the fastest rate during 2022-2030.

Regional-Based Insights

Based on geography, the infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the global infectious disease diagnostics market. Asia Pacific is expected to register the highest CAGR in the infectious disease diagnostics market during 2022-2030. The infectious diseases diagnostics market growth in the US is primarily driven by the increasing prevalence of infectious diseases, rising geriatric population, and growing number of product launches by key players.

Abbott Laboratories, Bruker Corp, Cardinal Health, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories, and DiaSorin SpA are among the prominent players operating in the infectious disease diagnostics market. These companies focus on new product launches and geographic expansions to meet the growing consumer demand across the world and increase their product range in specialty portfolios. Their global presence allows them to serve a large base of customers, subsequently facilitating market expansion.

A few of the major primary and secondary sources referred to while preparing the report on the infectious disease diagnostics market are the World Health Organization (WHO), the US Census Bureau, The Journal for Infectious Diseases, International Journal of Infectious Diseases, and CDC, among others.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the infectious disease diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global infectious disease diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global infectious disease diagnostics market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction 39

1.1 The Insight Partners Research Report Guidance. 39
1.2 Market Segmentation. 40

2. Executive Summary 42

2.1 Key Insights. 42
2.2 Infectious Disease Diagnostics Market, by Geography (US$ Million) 43

3. Research Methodology 44

3.1 Coverage. 45
3.2 Secondary Research. 45
3.3 Primary Research. 45

4. Infectious Disease Diagnostics Market Landscape 47

4.1 Overview. 47
4.2 PEST Analysis. 47
- 4.2.1 Global PEST Analysis. 47

5. Infectious Disease Diagnostics Market - Key Industry Dynamics 48

5.1 Market Drivers: 48
- 5.1.1 Rising Incidence of Infectious Diseases. 48
- 5.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease. 50
5.2 Market Restraints. 50
- 5.2.1 Inadequate Reimbursement Scenario. 50
5.3 Market Opportunities. 51
- 5.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics. 51
5.4 Future Trends. 52
- 5.4.1 Rising Number of Product Approvals and Launches. 52
5.5 Impact Analysis: 52

6. Infectious Disease Diagnostics Market - Global Market Analysis 54

6.1 Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030. 54

7. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Product 56

7.1 Overview. 56
7.2 Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%) 56
7.3 Kits & Reagents. 57
- 7.3.1 Overview. 57
- 7.3.2 Kits & Reagents: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 57
7.4 Instruments. 58
- 7.4.1 Overview. 58
- 7.4.2 Instruments: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 58
7.5 Software & Services. 59
- 7.5.1 Overview. 59
- 7.5.2 Software & Services: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 59

8. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Technology 60

8.1 Overview. 60
8.2 Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%) 60
8.3 Biosensor-based. 61
- 8.3.1 Overview. 61
- 8.3.2 Biosensor-based: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 61
8.4 Immunodiagnostics. 62
- 8.4.1 Overview. 62
- 8.4.2 Immunodiagnostics: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 62
  - 8.4.2.1 Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 63
8.5 Molecular-Based Diagnostic Techniques. 64
- 8.5.1 Overview. 64
- 8.5.2 Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 64
  - 8.5.2.1 Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 64
8.6 Clinical Biology. 66
- 8.6.1 Overview. 66
- 8.6.2 Clinical Biology: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 66
8.7 Others. 67
- 8.7.1 Overview. 67
- 8.7.2 Others: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 67

9. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Application Type 68

9.1 Overview. 68
9.2 Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%) 68
9.3 Point-of-Care Testing. 69
- 9.3.1 Overview. 69
- 9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 69
9.4 Laboratory Testing. 70
- 9.4.1 Overview. 70
- 9.4.2 Laboratory Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 70

10. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Testing Type 71

10.1 Overview. 71
10.2 Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%) 71
10.3 Human Testing. 72
- 10.3.1 Overview. 72
- 10.3.2 Human Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 72
  - 10.3.2.1 Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 73
10.4 Veterinary Testing. 74
- 10.4.1 Overview. 74
- 10.4.2 Veterinary Testing: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 74

11. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by End User 75

11.1 Overview. 75
11.2 Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%) 75
11.3 Diagnostic Laboratories. 76
- 11.3.1 Overview. 76
- 11.3.2 Diagnostic Laboratories: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 76
11.4 Hospitals and Clinics. 77
- 11.4.1 Overview. 77
- 11.4.2 Hospitals and Clinics: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 77
11.5 Research Institutes. 78
- 11.5.1 Overview. 78
- 11.5.2 Research Institutes: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 78
11.6 Homecare Settings. 80
- 11.6.1 Overview. 80
- 11.6.2 Homecare Settings: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 80
11.7 Others. 81
- 11.7.1 Overview. 81
- 11.7.2 Others: Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 81

12. Infectious Disease Diagnostics Market - Geographical Analysis 82

12.1 North America Infectious Disease Diagnostics Market, Revenue and Forecast To 2030. 82
- 12.1.1 Overview. 82
- 12.1.2 North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 83
- 12.1.3 North America: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 83
- 12.1.4 North America: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 84
  - 12.1.4.1 North America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 84
  - 12.1.4.2 North America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 85
- 12.1.5 North America: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 85
- 12.1.6 North America: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 86
  - 12.1.6.1 North America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 86
- 12.1.7 North America: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 87
- 12.1.8 North America Infectious Disease Diagnostics Market, by Country. 87
  - 12.1.8.1 US. 88
    - 12.1.8.1.1 Overview
    - 12.1.8.1.2 US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 88
    - 12.1.8.1.3 US: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 88
    - 12.1.8.1.4 US: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 90
    - 12.1.8.1.4.1 US: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 90
    - 12.1.8.1.4.2 US: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 91
    - 12.1.8.1.5 US: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 92
    - 12.1.8.1.6 US: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 92
    - 12.1.8.1.6.1 US: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 92
    - 12.1.8.1.7 US: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 93
  - 12.1.8.2 Canada. 94
    - 12.1.8.2.1 Overview
    - 12.1.8.2.2 Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 94
    - 12.1.8.2.3 Canada: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 95
    - 12.1.8.2.4 Canada: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 96
    - 12.1.8.2.4.1 Canada: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 96
    - 12.1.8.2.4.2 Canada: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 97
    - 12.1.8.2.5 Canada: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 97
    - 12.1.8.2.6 Canada: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 98
    - 12.1.8.2.6.1 Canada: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 98
    - 12.1.8.2.7 Canada: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 99
  - 12.1.8.3 Mexico. 100
    - 12.1.8.3.1 Overview
    - 12.1.8.3.2 Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 100
    - 12.1.8.3.3 Mexico: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 101
    - 12.1.8.3.4 Mexico: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 102
    - 12.1.8.3.4.1 Mexico: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 102
    - 12.1.8.3.4.2 Mexico: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 103
    - 12.1.8.3.5 Mexico: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 103
    - 12.1.8.3.6 Mexico: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 103
    - 12.1.8.3.6.1 Mexico: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 104
    - 12.1.8.3.7 Mexico: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 104
12.2 Europe Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 105
- 12.2.1 Overview. 105
- 12.2.2 Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 106
- 12.2.3 Europe: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 106
- 12.2.4 Europe: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 107
  - 12.2.4.1 Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 107
  - 12.2.4.2 Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 108
- 12.2.5 Europe: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 108
- 12.2.6 Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 109
  - 12.2.6.1 Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 109
- 12.2.7 Europe: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 110
- 12.2.8 Europe Infectious Disease Diagnostics Market, by Country. 110
  - 12.2.8.1 UK
    - 12.2.8.1.1 Overview
    - 12.2.8.1.2 UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 111
    - 12.2.8.1.3 UK: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 111
    - 12.2.8.1.4 UK: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 113
    - 12.2.8.1.4.1 UK: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 113
    - 12.2.8.1.4.2 UK: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 114
    - 12.2.8.1.5 UK: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 114
    - 12.2.8.1.6 UK: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 115
    - 12.2.8.1.6.1 UK: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 115
    - 12.2.8.1.7 UK: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 116
  - 12.2.8.2 Germany. 117
    - 12.2.8.2.1 Overview
    - 12.2.8.2.2 Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 117
    - 12.2.8.2.3 Germany: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 118
    - 12.2.8.2.4 Germany: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 119
    - 12.2.8.2.4.1 Germany: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 119
    - 12.2.8.2.4.2 Germany: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 120
    - 12.2.8.2.5 Germany: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 120
    - 12.2.8.2.6 Germany: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 121
    - 12.2.8.2.6.1 Germany: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 121
    - 12.2.8.2.7 Germany: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 122
  - 12.2.8.3 France. 123
    - 12.2.8.3.1 Overview
    - 12.2.8.3.2 France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 123
    - 12.2.8.3.3 France: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 123
    - 12.2.8.3.4 France: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 125
    - 12.2.8.3.4.1 France: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 125
    - 12.2.8.3.4.2 France: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 126
    - 12.2.8.3.5 France: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 126
    - 12.2.8.3.6 France: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 127
    - 12.2.8.3.6.1 France: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 127
    - 12.2.8.3.7 France: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 128
  - 12.2.8.4 Italy. 129
    - 12.2.8.4.1 Overview
    - 12.2.8.4.2 Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 129
    - 12.2.8.4.3 Italy: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 129
    - 12.2.8.4.4 Italy: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 131
    - 12.2.8.4.4.1 Italy: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 131
    - 12.2.8.4.4.2 Italy: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 132
    - 12.2.8.4.5 Italy: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 132
    - 12.2.8.4.6 Italy: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 132
    - 12.2.8.4.6.1 Italy: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 133
    - 12.2.8.4.7 Italy: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 133
  - 12.2.8.5 Spain. 134
    - 12.2.8.5.1 Overview
    - 12.2.8.5.2 Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 134
    - 12.2.8.5.3 Spain: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 134
    - 12.2.8.5.4 Spain: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 136
    - 12.2.8.5.4.1 Spain: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 136
    - 12.2.8.5.4.2 Spain: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 137
    - 12.2.8.5.5 Spain: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 137
    - 12.2.8.5.6 Spain: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 137
    - 12.2.8.5.6.1 Spain: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 138
    - 12.2.8.5.7 Spain: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 138
  - 12.2.8.6 Rest of Europe. 139
    - 12.2.8.6.1 Overview
    - 12.2.8.6.2 Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 139
    - 12.2.8.6.3 Rest of Europe: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 139
    - 12.2.8.6.4 Rest of Europe: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 141
    - 12.2.8.6.4.1 Rest of Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 141
    - 12.2.8.6.4.2 Rest of Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 142
    - 12.2.8.6.5 Rest of Europe: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 142
    - 12.2.8.6.6 Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 143
    - 12.2.8.6.6.1 Rest of Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 143
    - 12.2.8.6.7 Rest of Europe: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 144
12.3 Asia Pacific Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 145
- 12.3.1 Overview. 145
- 12.3.2 Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 146
- 12.3.3 Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 146
- 12.3.4 Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 147
  - 12.3.4.1 Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 147
  - 12.3.4.2 Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 148
- 12.3.5 Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 148
- 12.3.6 Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 149
  - 12.3.6.1 Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 149
- 12.3.7 Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 150
- 12.3.8 Asia Pacific Infectious Disease Diagnostics Market, by Country. 151
  - 12.3.8.1 China. 151
    - 12.3.8.1.1 Overview
    - 12.3.8.1.2 China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 151
    - 12.3.8.1.3 China: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 153
    - 12.3.8.1.4 China: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 153
    - 12.3.8.1.4.1 China: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 154
    - 12.3.8.1.4.2 China: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 154
    - 12.3.8.1.5 China: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 155
    - 12.3.8.1.6 China: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 155
    - 12.3.8.1.6.1 China: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 156
    - 12.3.8.1.7 China: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 156
  - 12.3.8.2 Japan. 157
    - 12.3.8.2.1 Overview
    - 12.3.8.2.2 Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 157
    - 12.3.8.2.3 Japan: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 157
    - 12.3.8.2.4 Japan: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 159
    - 12.3.8.2.4.1 Japan: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 159
    - 12.3.8.2.4.2 Japan: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 160
    - 12.3.8.2.5 Japan: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 160
    - 12.3.8.2.6 Japan: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 160
    - 12.3.8.2.6.1 Japan: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 161
    - 12.3.8.2.7 Japan: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 161
  - 12.3.8.3 India. 162
    - 12.3.8.3.1 Overview
    - 12.3.8.3.2 India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 162
    - 12.3.8.3.3 India: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 162
    - 12.3.8.3.4 India: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 164
    - 12.3.8.3.4.1 India: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 164
    - 12.3.8.3.4.2 India: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 165
    - 12.3.8.3.5 India: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 165
    - 12.3.8.3.6 India: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 165
    - 12.3.8.3.6.1 India: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 166
    - 12.3.8.3.7 India: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 166
  - 12.3.8.4 South Korea. 167
    - 12.3.8.4.1 Overview
    - 12.3.8.4.2 South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 167
    - 12.3.8.4.3 South Korea: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 167
    - 12.3.8.4.4 South Korea: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 169
    - 12.3.8.4.4.1 South Korea: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 169
    - 12.3.8.4.4.2 South Korea: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 170
    - 12.3.8.4.5 South Korea: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 170
    - 12.3.8.4.6 South Korea: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 170
    - 12.3.8.4.6.1 South Korea: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 171
    - 12.3.8.4.7 South Korea: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 171
  - 12.3.8.5 Australia. 172
    - 12.3.8.5.1 Overview
    - 12.3.8.5.2 Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 172
    - 12.3.8.5.3 Australia: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 172
    - 12.3.8.5.4 Australia: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 174
    - 12.3.8.5.4.1 Australia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 174
    - 12.3.8.5.4.2 Australia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 175
    - 12.3.8.5.5 Australia: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 175
    - 12.3.8.5.6 Australia: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 175
    - 12.3.8.5.6.1 Australia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 176
    - 12.3.8.5.7 Australia: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 176
  - 12.3.8.6 Rest of Asia Pacific. 177
    - 12.3.8.6.1 Overview
    - 12.3.8.6.2 Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 177
    - 12.3.8.6.3 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 177
    - 12.3.8.6.4 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 179
    - 12.3.8.6.4.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 179
    - 12.3.8.6.4.2 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 180
    - 12.3.8.6.5 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 180
    - 12.3.8.6.6 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 181
    - 12.3.8.6.6.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 181
    - 12.3.8.6.7 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 182
12.4 Middle East & Africa Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 183
- 12.4.1 Overview. 183
- 12.4.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 184
- 12.4.3 Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 184
- 12.4.4 Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 185
  - 12.4.4.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 185
  - 12.4.4.2 Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 186
- 12.4.5 Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 186
- 12.4.6 Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 187
  - 12.4.6.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 187
- 12.4.7 Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 188
  - 12.4.7.1 Middle East & Africa Infectious Disease Diagnostics Market, by Country. 188
  - 12.4.7.2 Saudi Arabia. 189
    - 12.4.7.2.1 Overview
    - 12.4.7.2.2 Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 189
    - 12.4.7.2.3 Saudi Arabia: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 189
    - 12.4.7.2.4 Saudi Arabia: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 191
    - 12.4.7.2.4.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 191
    - 12.4.7.2.4.2 Saudi Arabia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 192
    - 12.4.7.2.5 Saudi Arabia: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 192
    - 12.4.7.2.6 Saudi Arabia: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 192
    - 12.4.7.2.6.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 193
    - 12.4.7.2.7 Saudi Arabia: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 193
  - 12.4.7.3 South Africa. 194
    - 12.4.7.3.1 Overview
    - 12.4.7.3.2 South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 194
    - 12.4.7.3.3 South Africa: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 194
    - 12.4.7.3.4 South Africa: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 196
    - 12.4.7.3.4.1 South Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 196
    - 12.4.7.3.4.2 South Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 197
    - 12.4.7.3.5 South Africa: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 197
    - 12.4.7.3.6 South Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 197
    - 12.4.7.3.6.1 South Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 198
    - 12.4.7.3.7 South Africa: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 198
  - 12.4.7.4 UAE. 199
    - 12.4.7.4.1 Overview
    - 12.4.7.4.2 UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 199
    - 12.4.7.4.3 UAE: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 199
    - 12.4.7.4.4 UAE: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 201
    - 12.4.7.4.4.1 UAE: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 201
    - 12.4.7.4.4.2 UAE: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 202
    - 12.4.7.4.5 UAE: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 202
    - 12.4.7.4.6 UAE: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 202
    - 12.4.7.4.6.1 UAE: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 203
    - 12.4.7.4.7 UAE: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 203
  - 12.4.7.5 Rest of Middle East & Africa. 204
    - 12.4.7.5.1 Overview
    - 12.4.7.5.2 Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 204
    - 12.4.7.5.3 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 204
    - 12.4.7.5.4 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 206
    - 12.4.7.5.4.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 206
    - 12.4.7.5.4.2 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 207
    - 12.4.7.5.5 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 207
    - 12.4.7.5.6 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 208
    - 12.4.7.5.6.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 208
    - 12.4.7.5.7 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 209
12.5 South & Central America Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 210
- 12.5.1 Overview. 210
- 12.5.2 South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 211
- 12.5.3 South & Central America: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 211
- 12.5.4 South & Central America: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 212
  - 12.5.4.1 South & Central America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 212
  - 12.5.4.2 South & Central America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 213
- 12.5.5 South & Central America: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 213
- 12.5.6 South & Central America: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 214
  - 12.5.6.1 South & Central America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 214
- 12.5.7 South & Central America: Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 215
- 12.5.8 South & Central America Infectious Disease Diagnostics Market, by Country. 215
  - 12.5.8.1 Brazil 216
    - 12.5.8.1.1 Overview
    - 12.5.8.1.2 Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 216
    - 12.5.8.1.3 Brazil: Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 216
    - 12.5.8.1.4 Brazil: Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 218
    - 12.5.8.1.4.1 Brazil: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 218
    - 12.5.8.1.4.2 Brazil: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 219
    - 12.5.8.1.5 Brazil: Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 219
    - 12.5.8.1.6 Brazil: Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 219
    - 12.5.8.1.6.1 Brazil: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 220
    - 12.5.8.1.7 Brazil: Infectious Disease Diagnostics Market, by End Use

感染症診断市場規模・予測、製品・技術・用途タイプ・検査タイプ・エンドユーザー・地域別の世界・地域シェア、動向、成長機会分析

Infectious Disease Diagnostics Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Product, Technology , Application Type, Testing Type, End User, and Geography

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章感染症診断市場の情勢

第5章感染症診断市場：主要産業力学

第6章感染症診断市場- 世界市場分析

第7章感染症診断の世界市場-2030年までの収益と予測-製品別

第8章感染症診断の世界市場-2030年までの収益と予測-技術別

第9章感染症診断の世界市場-2030年までの収益と予測-用途別

第10章感染症診断の世界市場：2030年までの収益と予測：検査タイプ別

第11章感染症診断の世界市場-2030年までの収益と予測-エンドユーザー別

第12章感染症診断市場：地域別分析

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction 39

2. Executive Summary 42

3. Research Methodology 44

4. Infectious Disease Diagnostics Market Landscape 47

5. Infectious Disease Diagnostics Market - Key Industry Dynamics 48

6. Infectious Disease Diagnostics Market - Global Market Analysis 54

7. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Product 56

8. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Technology 60

9. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Application Type 68

10. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Testing Type 71

11. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by End User 75

12. Infectious Disease Diagnostics Market - Geographical Analysis 82

感染症診断市場規模・予測、製品・技術・用途タイプ・検査タイプ・エンドユーザー・地域別の世界・地域シェア、動向、成長機会分析

Infectious Disease Diagnostics Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Product, Technology , Application Type, Testing Type, End User, and Geography

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 感染症診断市場の情勢

第5章 感染症診断市場：主要産業力学

第6章 感染症診断市場- 世界市場分析

第7章 感染症診断の世界市場-2030年までの収益と予測-製品別

第8章 感染症診断の世界市場-2030年までの収益と予測-技術別

第9章 感染症診断の世界市場-2030年までの収益と予測-用途別

第10章 感染症診断の世界市場：2030年までの収益と予測：検査タイプ別

第11章 感染症診断の世界市場-2030年までの収益と予測-エンドユーザー別

第12章 感染症診断市場：地域別分析

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction 39

2. Executive Summary 42

3. Research Methodology 44

4. Infectious Disease Diagnostics Market Landscape 47

5. Infectious Disease Diagnostics Market - Key Industry Dynamics 48

6. Infectious Disease Diagnostics Market - Global Market Analysis 54

7. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Product 56

8. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Technology 60

9. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Application Type 68

10. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Testing Type 71

11. Global Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by End User 75

12. Infectious Disease Diagnostics Market - Geographical Analysis 82

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章感染症診断市場の情勢

第5章感染症診断市場：主要産業力学

第6章感染症診断市場- 世界市場分析

第7章感染症診断の世界市場-2030年までの収益と予測-製品別

第8章感染症診断の世界市場-2030年までの収益と予測-技術別

第9章感染症診断の世界市場-2030年までの収益と予測-用途別

第10章感染症診断の世界市場：2030年までの収益と予測：検査タイプ別

第11章感染症診断の世界市場-2030年までの収益と予測-エンドユーザー別

第12章感染症診断市場：地域別分析